• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 蛋白信号通路报告基因筛选发现 nsp5 是 p53 活性的抑制剂。

Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.

机构信息

Department of Oral Biology, University of Florida College of Dentistry, 1395 Center Drive, Gainesville, FL 32610, USA.

Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL 32610, USA.

出版信息

Viruses. 2022 May 13;14(5):1039. doi: 10.3390/v14051039.

DOI:10.3390/v14051039
PMID:35632779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9145535/
Abstract

The dysregulation of host signaling pathways plays a critical role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and viral pathogenesis. While a number of viral proteins that can block type I IFN signaling have been identified, a comprehensive analysis of SARS-CoV-2 proteins in the regulation of other signaling pathways that can be critical for viral infection and its pathophysiology is still lacking. Here, we screened the effect of 21 SARS-CoV-2 proteins on 10 different host signaling pathways, namely, Wnt, p53, TGFβ, c-Myc, Hypoxia, Hippo, AP-1, Notch, Oct4/Sox2, and NF-κB, using a luciferase reporter assay. As a result, we identified several SARS-CoV-2 proteins that could act as activators or inhibitors for distinct signaling pathways in the context of overexpression in HEK293T cells. We also provided evidence for p53 being an intrinsic host restriction factor of SARS-CoV-2. We found that the overexpression of p53 is capable of reducing virus production, while the main viral protease nsp5 can repress the transcriptional activity of p53, which depends on the protease function of nsp5. Taken together, our results provide a foundation for future studies, which can explore how the dysregulation of specific signaling pathways by SARS-CoV-2 proteins can control viral infection and pathogenesis.

摘要

宿主信号通路的失调在严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染和病毒发病机制中起着关键作用。虽然已经鉴定出许多可以阻断 I 型干扰素信号的病毒蛋白,但对 SARS-CoV-2 蛋白在调节其他对病毒感染及其病理生理学至关重要的信号通路方面的全面分析仍有待研究。在这里,我们使用萤光素酶报告基因测定法筛选了 21 种 SARS-CoV-2 蛋白对 10 种不同宿主信号通路(Wnt、p53、TGFβ、c-Myc、缺氧、Hippo、AP-1、Notch、Oct4/Sox2 和 NF-κB)的影响。结果,我们鉴定出几种 SARS-CoV-2 蛋白,它们可以在 HEK293T 细胞中转录过表达的情况下作为不同信号通路的激活剂或抑制剂发挥作用。我们还提供了证据表明 p53 是 SARS-CoV-2 的内在宿主限制因子。我们发现 p53 的过表达能够降低病毒产量,而主要的病毒蛋白酶 nsp5 能够抑制 p53 的转录活性,这依赖于 nsp5 的蛋白酶功能。总之,我们的研究结果为进一步研究 SARS-CoV-2 蛋白如何通过调节特定信号通路来控制病毒感染和发病机制奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/813dfa91c6ec/viruses-14-01039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/3c69493e9bca/viruses-14-01039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/03ce58f59924/viruses-14-01039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/813dfa91c6ec/viruses-14-01039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/3c69493e9bca/viruses-14-01039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/03ce58f59924/viruses-14-01039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/521d/9145535/813dfa91c6ec/viruses-14-01039-g003.jpg

相似文献

1
Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity.SARS-CoV-2 蛋白信号通路报告基因筛选发现 nsp5 是 p53 活性的抑制剂。
Viruses. 2022 May 13;14(5):1039. doi: 10.3390/v14051039.
2
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.SARS-CoV-2 的蛋白酶 PLpro 和 3CLpro 可切割 IRF3 以及炎症途径的关键调节剂(NLRP12 和 TAB1):对跨物种疾病表现的影响。
Emerg Microbes Infect. 2021 Dec;10(1):178-195. doi: 10.1080/22221751.2020.1870414.
3
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.SARS-CoV-2 nsp5 表现出比其 SARS-CoV 同源物更强的催化活性和干扰素拮抗作用。
J Virol. 2022 Apr 27;96(8):e0003722. doi: 10.1128/jvi.00037-22. Epub 2022 Apr 7.
4
Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.HDAC2 与 SARS-CoV-2 NSP5 和 IRF3 的相互作用对于 NSP5 介导的Ⅰ型干扰素信号通路抑制并非必需。
Microbiol Spectr. 2022 Oct 26;10(5):e0232222. doi: 10.1128/spectrum.02322-22. Epub 2022 Sep 29.
5
Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶对 TRMT1 tRNA 修饰酶的蛋白水解切割和失活。
Elife. 2024 May 30;12:RP90316. doi: 10.7554/eLife.90316.
6
SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.SARS-CoV-2 Nsp5 通过上调 MAVS 的 SUMOylation 激活 NF-κB 通路。
Front Immunol. 2021 Nov 10;12:750969. doi: 10.3389/fimmu.2021.750969. eCollection 2021.
7
SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.严重急性呼吸综合征冠状病毒2型主要蛋白酶通过阻止磷酸化干扰素调节因子3的核转位来抑制I型干扰素的产生。
Int J Biol Sci. 2021 Apr 10;17(6):1547-1554. doi: 10.7150/ijbs.59943. eCollection 2021.
8
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.SARS-CoV-2 的 NSP5 和 N 蛋白通过抑制应激颗粒的形成来抑制 RIG-I 信号通路。
Signal Transduct Target Ther. 2022 Jan 24;7(1):22. doi: 10.1038/s41392-022-00878-3.
9
Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity.猪德尔塔冠状病毒 nsp5 切割 DCP1A 以降低其抗病毒活性。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.02162-19.
10
A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity.用于评估冠状病毒 Nsp5/3CLpro 活性的海肾荧光素酶报告基因检测法。
Sci Rep. 2024 Sep 5;14(1):20697. doi: 10.1038/s41598-024-71305-6.

引用本文的文献

1
The coronavirus 3CL protease: Unveiling its complex host interactions and central role in viral pathogenesis.冠状病毒3CL蛋白酶:揭示其复杂的宿主相互作用及在病毒发病机制中的核心作用。
Virol Sin. 2025 Aug;40(4):509-519. doi: 10.1016/j.virs.2025.07.002. Epub 2025 Jul 7.
2
Amino acid T25 in the substrate-binding domain of SARS-CoV-2 nsp5 is involved in viral replication in the mouse lung.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白5(nsp5)底物结合结构域中的氨基酸T25参与小鼠肺部的病毒复制。
PLoS One. 2024 Dec 6;19(12):e0312800. doi: 10.1371/journal.pone.0312800. eCollection 2024.
3
Losartan and enalapril maleate differently influence SARS-CoV-2-infected vero cells.

本文引用的文献

1
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy.SARS-CoV-2 ORF10 通过线粒体自噬降解 MAVS 来抑制抗病毒先天免疫反应。
Cell Mol Immunol. 2022 Jan;19(1):67-78. doi: 10.1038/s41423-021-00807-4. Epub 2021 Nov 29.
2
The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.17 种 SARS-CoV-2 蛋白的近端蛋白质组与抗病毒信号和宿主翻译的破坏有关。
PLoS Pathog. 2021 Oct 1;17(10):e1009412. doi: 10.1371/journal.ppat.1009412. eCollection 2021 Oct.
3
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates.
氯沙坦和马来酸依那普利对感染 SARS-CoV-2 的vero 细胞的影响不同。
Sci Rep. 2024 Oct 22;14(1):24801. doi: 10.1038/s41598-024-76657-7.
4
Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.SARS-CoV-2 与人类靶细胞的相互作用——代谢视角。
Int J Mol Sci. 2024 Sep 16;25(18):9977. doi: 10.3390/ijms25189977.
5
The diversification of methods for studying cell-cell interactions and communication.细胞间相互作用和通讯研究方法的多样化。
Nat Rev Genet. 2024 Jun;25(6):381-400. doi: 10.1038/s41576-023-00685-8. Epub 2024 Jan 18.
6
SARS-CoV-2 and the DNA damage response.SARS-CoV-2 与 DNA 损伤反应。
J Gen Virol. 2023 Nov;104(11). doi: 10.1099/jgv.0.001918.
7
Identification of Key Genes Related to Immune Cells in Patients with COVID-19 Via Integrated Bioinformatics-Based Analysis.基于整合生物信息学分析的 COVID-19 患者免疫细胞相关关键基因的鉴定。
Biochem Genet. 2023 Dec;61(6):2650-2671. doi: 10.1007/s10528-023-10400-1. Epub 2023 May 24.
8
The Wheel of p53 Helps to Drive the Immune System.p53 之轮助力驱动免疫系统。
Int J Mol Sci. 2023 Apr 21;24(8):7645. doi: 10.3390/ijms24087645.
9
Roles of p53-Mediated Host-Virus Interaction in Coronavirus Infection.p53 介导的宿主-病毒相互作用在冠状病毒感染中的作用。
Int J Mol Sci. 2023 Mar 28;24(7):6371. doi: 10.3390/ijms24076371.
10
Deep learning-based network pharmacology for exploring the mechanism of licorice for the treatment of COVID-19.基于深度学习的网络药理学探索甘草治疗 COVID-19 的机制。
Sci Rep. 2023 Apr 10;13(1):5844. doi: 10.1038/s41598-023-31380-7.
新型冠状病毒肺炎的动物模型:仓鼠、小鼠、雪貂、水貂、树鼩和非人灵长类动物。
Front Microbiol. 2021 Aug 31;12:626553. doi: 10.3389/fmicb.2021.626553. eCollection 2021.
4
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.低氧诱导因子 1α 促进严重急性呼吸综合征冠状病毒 2 感染并加重 COVID-19 的炎症反应。
Signal Transduct Target Ther. 2021 Aug 18;6(1):308. doi: 10.1038/s41392-021-00726-w.
5
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.SARS-CoV-2 辅助蛋白在病毒发病机制中的作用:已知和未知。
Front Immunol. 2021 Jul 7;12:708264. doi: 10.3389/fimmu.2021.708264. eCollection 2021.
6
Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.SARS-CoV-2 的 ORF7a 蛋白介导的 NF-κB 激活和促炎细胞因子表达的诱导。
Sci Rep. 2021 Jun 29;11(1):13464. doi: 10.1038/s41598-021-92941-2.
7
The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications.Notch信号通路:新冠病毒病理生理学与其心血管并发症之间的联系
Front Cardiovasc Med. 2021 May 26;8:681948. doi: 10.3389/fcvm.2021.681948. eCollection 2021.
8
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.严重 COVID-19 中的 SARS-CoV-2 诱导 TGF-β 主导的慢性免疫反应,但不针对自身。
Nat Commun. 2021 Mar 30;12(1):1961. doi: 10.1038/s41467-021-22210-3.
9
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.全基因组 CRISPR 筛选鉴定 TMEM106B 为 SARS-CoV-2 的前病毒宿主因子。
Nat Genet. 2021 Apr;53(4):435-444. doi: 10.1038/s41588-021-00805-2. Epub 2021 Mar 8.
10
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗策略:对3期候选疫苗的全面综述
NPJ Vaccines. 2021 Feb 22;6(1):28. doi: 10.1038/s41541-021-00292-w.